Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-g7rbq Total loading time: 0 Render date: 2024-07-26T14:32:39.689Z Has data issue: false hasContentIssue false
This chapter is part of a book that is no longer available to purchase from Cambridge Core

44 - Galantamine

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Nancy Muntner
Affiliation:
Neuroscience Education Institute
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 146 - 148
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ballard, CG, Chalmers, KA, Todd, C, McKeith, IG, O'Brien, JT, Wilcock, G, Love, S, Perry, EK. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology 2007;68(20):1726–9.Google Scholar
Bentué-Ferrer, D, Tribut, O, Polard, E, Allain, H. Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists. CNS Drugs 2003;17(13):947–63.Google Scholar
Bhasin, M, Rowan, E, Edwards, K, McKeith, I. Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. Int J Geriatr Psychiatry 2007;22(9):890–5.Google Scholar
Downey, D. Pharmacologic management of Alzheimer disease. J Neurosci Nurs 2008;40(1):55–9.Google Scholar
Edwards, K, Royall, D, Hershey, L, Lichter, D, Hake, A, Farlow, M, Pasquier, F, Johnson, S. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dement Geriatr Cogn Disord 2007;23(6):401–5.Google Scholar
Olin, J, Schneider, L. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev 2002;(3):CD001747.Google Scholar
Stahl, SM. The new cholinesterase inhibitors for Alzheimer's disease, Part 1: their similarities are different. J Clin Psychiatry 2000;61(10):710–11.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×